T he onset of type 2 diabetes in both human and rodent models is accompanied by a progressive decrease in ß-cell mass, resulting from increased ß-cell apoptosis (1) . Many physiological and pathophysiological states such as pregnancy, nondiabetic obesity, aging, genetic insulin resistance, and acute illness increase systemic insulin demand (2) . To compensate for relative insulin deficiency, pancreatic ß-cells dynamically expand their mass. Although insulin resistance arises during metabolic stress, it is the inability of the ß-cell to meet the demand for insulin that ultimately leads to type 2 diabetes.
Whereas the ability of the adult pancreas to modulate ß-cell mass has been clearly demonstrated, at least in rodents, there is controversy regarding the mechanisms underlying the expansion of ß-cell mass. These mechanisms include replication of preexisting ß-cells, differentiation of progenitors within the ductal epithelium, transdifferentiation of acinar cells, and differentiation of pancreatic stem cells and/or progenitors that are not of ß-cell, ductal, or acinar origin (3) . Recent studies indicate that during adulthood the great majority of new ß-cells in mice are derived through replication or preexisting ß-cells and few, if any, newly formed ß-cells stem from progenitor cell populations (4) . Only under extreme conditions is the fetal differentiation program, involving the basic helix loop helix factor Ngn3, reactivated in the adult mouse (5), indicating that terminally differentiated rodent ß-cells retain a significant capacity to proliferate in vivo.
Adult ß-cells undergo very little turnover and are estimated to have an average lifespan of approximately 60 d in the mouse (6) , with turnover being even rarer in islets of adult humans (7) . Therefore, it is often necessary to introduce a metabolic stress that increases the demand for insulin to expose the effects of mutations affecting ß-cell expansion. Such an approach has been used to study the role of Pdx1 (8) and Hnf4␣ (9) in the maintenance of ß-cell mass.
One of the most robust physiological stimuli of ß-cell expansion is pregnancy. Studies in rats demonstrated that ß-cell proliferation increases dramatically during pregnancy, with a peak occurring about two thirds of the way through gestation and returning to prepartum levels after d 18.5, as assessed through bromodeoxyuridine (BrdU) incorporation into DNA (10) . This peak in proliferation coincides with the peak of placental lactogen levels. However, it remains unclear which mechanisms specifically drive ß-cell replication during pregnancy in vivo. In this study we systematically uncover pathways and factors underlying the islet's proliferative response to pregnancy in vivo, because these targets might be exploited in the treatment of diabetes.
Results

ß-Cell proliferation and ß-cell hypertrophy dramatically increase ß-cell mass during pregnancy
To rigorously examine the modulation of ß-cell mass in the adult mouse during pregnancy, we assessed ß-cell mass in both nonpregnant control and pregnant female mice specifically at d 14.5 of gestation, corresponding to the peak BrdU labeling in the rodent (10) . Using morphometric analysis, we found that ß-cell mass was increased 3.8 times on d 14.5 of pregnancy compared with nonpregnant controls (Fig. 1A) . The increase in ß-cell mass was strongly correlated with increased BrdU incorporation into DNA. On average, nonpregnant controls exhibited 1.14 BrdU-positive cells per islet cross-section, and 1.04% of all islet nuclei were BrdU positive. Conversely, BrdU labeling was increased to 4.02 BrdU-positive cells per islet cross-section and 3.58% of cells on d 14.5 of gestation (Fig. 1, B and C) . In pregnant animals almost all islets contained at least one BrdU-positive cell, but many contained five to 10 or even more BrdU-positive cells (Fig.  1D ). Insulin and BrdU immunostaining confirmed that it was indeed ß-cells that were proliferating (Fig. 2, A-F) . Figure 2 also illustrates the appearance of doublet BrdUstained nuclei, showing an increase of newly formed daughter cells, specifically as a result of ß-cell mitosis. Ki67 antigen detection also confirmed the dramatic increase in ß-cell proliferation on d 14.5 of gestation (Fig. 2 , G and H), and closely mirrored a 4.8-fold increase in mKi67 mRNA expression (data not shown). In addition, the expression levels of cyclin A2, B1, B2, D3, E1, F, and Cdk4 were significantly increased, whereas expression of Cdk6 and Cdk7 was significantly decreased as compared with islets from control mice (Fig. 1G) . Concurrently with ß-cell proliferation, ß-cell hypertrophy occurred (Fig. 2, I and J) because ß-cell size, as measured by volume, was increased approximately three times on d 14.5 of pregnancy ( Fig. 1E ) with an overall shift toward larger ß-cells (Fig. 1F ).
Identification of differentially expressed genes throughout pregnancy in the islet
Whereas the dramatic proliferative response of the pancreatic ß-cell that occurs during pregnancy has been ccna2  ccnb1  ccnb2  ccnc  ccnd1  ccnd2  ccnd3  ccne1  ccne2  ccnf  ccnh  cdk1  cdk2  cdk3  cdk4  cdk6  cdk7  Relative known for some time (10) , no systematic study that investigates the expression profile of this response has been reported thus far. (11) . In addition, not only are these genes differentially expressed concurrently with the peak of ß-cell proliferation, but, for the 18 genes tested, also at d 10.5 when ß-cell replication is thought to initiate (Fig. 3 , A-R). The majority of genes are also differentially expressed during d 18.5 possibly reflecting potential further roles in the islet during pregnancy independent from replication.
Differentially expressed genes are present in ß-cells
To investigate whether the expression of differentially expressed genes during pregnancy we found in islets are expressed in ß-cells, we used Mip-GFP (mouse insulin promoter-green fluorescent protein) transgenic mice to enrich for ß-cells (12) . We prepared single-cell suspensions from isolated islets and separated GFPϩ ß-cells from GFPϪ non-ß-cells, by fluorescence-activated cell sorting. Although sorting of GFPϩ and GFPϪ fractions was successful (supplemental Fig. 2 ), significant levels of insulin and Pdx1 mRNA were present in the GFPϪ fractions, at levels many orders of magnitude higher then RNA isolated from wild-type livers (Fig. 4, A and B ). This indicates that not all ß-cells in Mip-GFP mice express high enough GFP to allow for sorting. Despite this limitation, we observed significantly elevated expression of a panel of genes in GFPϩ compared with GFPϪ cells derived from pregnant 14.5 islets for all genes except Gdf3 (Fig. 4 , E-O). This confirms that the majority of the islet-specific differentially expressed genes described above are indeed expressed in ß-cells during pregnancy and is consistent with their proposed role in regulating ß-cell replication during gestation. Although both proliferative and survival signals are required for islet expansion, the mechanisms to attain increased islet mass differ between pregnancy, obesity, and ß-cell injury models
To identify specific pathways and mechanisms that potentially contribute to ß-cell proliferation observed during d 14.5 of pregnancy, we analyzed our expression data with the Database for Annotation, Visualization and Integrated Discovery (DAVID), which is specifically designed to systematically extract biological meaning from large gene lists (13) . Among the biological functions demonstrating significant enrichment among the genes differentially expressed in islets during pregnancy, 228 genes are involved in processes relating to cellular proliferation, and 60 with apoptosis. Interestingly, other functions enriched during pregnancy d 14.5 include antioxidation and free radical removal, vesicle-mediated transport, ubiquitin cycle, proteolysis, and chromatin packaging and remodeling (Table 2) . Gene Set Enrichment Analysis (GSEA) identified gene sets up-regulated during pregnancy involved in both tryptophan metabolism and ERK pathway (data not shown) (14) .
Functional characterization of genes differentially expressed during pregnancy d 14.5 suggests that the islet's ability to compensate during metabolic stress requires the simultaneous induction of both proliferative and survival pathways. During pregnancy the increase in proliferation specifically in the ß-cell is accompanied by a 5-fold increase in Birc5 gene expression in the islet (Table 1) . Conditional deletion of Birc5, an inhibitor of apoptosis, specifically in the endocrine pancreas, showed a severe inability to maintain normal postnatal ß-cell mass throughout adulthood in vivo (15) . We hypothesized that simultaneous induction of Birc5 expression in the islet with ß-cell proliferation during other models of ß-cell expansion is essential for the ability of the islet to expand its mass in response to diverse metabolic stressors. To address this issue, we assessed mKi67 and Birc5 gene expression in two additional ß-cell expansion models: the diabetes-resistant B6 leptin ob/ob and diabetes-susceptible BTBR leptin ob/ob mice (16) , and the PANIC-ATTAC transgenic mouse model of inducible and reversible ß-cell ablation (17) . Leptin-deficient B6 mice that remain nondiabetic, irrespective of obesity, were able to induce the expression of both mKi67 and Birc5 throughout obesity both at 4 and 10 wk of age (Fig. 5A) . In contrast, although initially able to significantly induce Birc5 expression at 4 wk, the 10-wk-old BTBR leptin ob/ob mice were unable to induce the expression of either gene, in part accounting for the onset of severe diabetes at this age (16) . The expression of Birc5 was significantly greater in the 10-wk-old B6 leptin ob/ob compared with the 10-wk-old BTBR leptin ob/ob mouse (Fig. 5A ).
ß-Cell mass is reversibly ablated by activation of caspase-8-mediated apoptosis in the PANIC-ATTAC model, and recovers in 30 d to pretreatment levels even in the face of severe hyperglycemia (17) (Fig. 5C ), suggesting the ability to successfully expand islet mass during pregnancy, obesity, or in the setting of injury-induced diabetes requires both the induction of both islet proliferation and survival pathways.
Given the divergent physiological contexts of pregnancy, obesity, and experimental ß-cell ablation, the molecular mechanisms responsible for both the compensatory increase in islet mass response are probably distinct. To address this issue, using qPCR, we compared the expression of selected genes most differentially expressed during pregnancy d 14.5 to two other models of ß-cell expansion: the 10-wk-old diabetes-resistant B6 leptin ob/ob mouse and the PANIC-ATTAC transgenic mouse. Whereas the expression of some genes such as Tnfrsf11b and Hopx significantly increased, the majority of gene expression did not change, declined, or was not detectable during obesity (Fig. 5B) . Genes whose temporal gene expression significantly changed during ß-cell recovery after injury included Itk, Tnfrsf11b, Il1rn, Rasgrp1, and Ngfr with the majority of gene changes occurring on d 8, the peak of proliferation (Fig. 5, D and E) . Again, the majority of gene expression profiles did not change or declined in the PANIC-ATTAC model (Fig. 5E) . Interestingly, Birc5, and Tnfrsf11b induction is connected to all three in vivo models of ß-cell mass expansion analyzed. However, the dramatic differences in gene induction occurring between pregnancy, obesity-induced ß-cell compensation, and recovery from ß-cell ablation suggest that diverse mechanisms can be used by the ß-cell to expand its mass. 
Discussion
The ability of the ß-cell to compensate for an increased insulin demand includes not only an increase in insulin secretion, but also an expansion of ß-cell mass by modulating the balance between both ß-cell proliferation and apoptosis. Here we investigated the global gene expression profile of the expanding islet during pregnancy at the peak of ß-cell proliferation. We identified nearly 2000 genes that are differentially expressed at this time when compared with nonpregnant controls. Several of the genes observed to be differentially expressed during pregnancy are known to function in the maintenance of ß-cell mass, including not only c-Myc, Cdk4, but both Prl2c5, and Prlr, consistent with the known role of placental lactogens during pregnancy-induced ß-cell mass expansion (18 -21) . Strikingly, many of the genes identified in our analysis have not been previously reported to play a role in islet expansion.
One of the most significantly regulated genes was the F-box and WD-40 domain protein 15 (Fbxw15). F-box proteins have been identified as substrate recognition components of the multi-subunit ubiquitin ligase SCF (SKP1-CUL1-F-box protein) and contribute to the regulation of cell cycle progression and cell fate via the ubiquitylation and consequent degradation of many cell cycle regulators such as p27 (22) and Cyclin D1 (23) . Differential expression of other F-box family members (C85627, Fbxw14, Fbxl17, Fbxl27, and Fbxo27) also occurs during pregnancy, signifying that tight regulation of specific cell cycle proteins by way of proteosomal protein degradation is a crucial process in the islet's adaptive ability response to metabolic stress.
Surprisingly, expression of key serotonin-synthesizing enzymes, tryptophan hydroxylase 1 and 2 (Tph1/2), were strongly induced during pregnancy. In Drosophila, serotonergic neurons in the brain were shown to control body size by regulating the insulin/IGF pathway in peripheral tissues (24) . In mice gene ablation studies show deletion of only the 5-hydoxytryptamine receptor 2C produces insulin resistance and type 2 diabetes (25), resulting in the extensive development of 5-hydoxytryptamine receptor 2C agonists that improve glucose homeostasis in leptin-deficient obese mice (26) . Serotonin itself has been shown to enhance insulin synthesis and secretion on primary rat islets in vitro (27) . However, although the relatively elevated presence of serotonin in pancreatic islets has been known for years (28), a specific growth-related role in ß-cells remains to be established.
We demonstrate by utilizing three different models of ß-cell expansion that both the islet's and ß-cell's ability to respond to different metabolic stresses is associated with both an increase in proliferation and survival mechanisms, supported by increases in mKi67 and Birc5 gene expression. ß-Cell specific overexpression of c-Myc in mice causes increased ß-cell proliferation, but also apoptosis leading to the development of diabetes (29) . Conversely, deletion of Caspase 3 protects the ß-cell from c-Myc-induced apoptosis and diabetes, supporting the notion that the ß-cell's ability to compensate during metabolic stress requires the simultaneous induction of both proliferative and survival pathways (30) . For example, dysregulation of this homeostatic control of ß-cell mass, based on the relative contribution of cell proliferation and cell death, is not only a major contributor to gestational diabetes, but also the onset of type 2 diabetes, because 70% of women who are diabetic during pregnancy develop type 2 diabetes later in life (31) . Our pregnancy gene list shows potential signaling factors involved in coordinating both of these processes not only in the islet, but potentially in the ß-cell itself.
Both Cish and Socs2, members of the suppressor of cytokine signaling family of proteins, have been shown to act as negative regulators of a variety of tyrosine kinases and receptors impacting ß-cell proliferation in vitro, including Prlr (32) and Igf1r (33), via a negative feedback loop and proteosomal degradation mechanisms, inhibiting their downstream Janus family of tyrosine kinase 2/signal transducer and activator of transcription signaling cascades. Cish and Socs2 are known to decrease activation of signal transducer and activator of transcription 5 (32, 34), the gene products of which induce proliferative (Cyclin D2), antiapoptotic (Bcl-xL, Bcl6) (35, 36, 50) , and functional mechanisms (Gck, Glut2, Insulin) (37, 38) . This suggests that the high levels of Cish and Socs2 expression observed during pregnancy play a critical role in limiting both the rate of cell proliferation and survival of ß-cells. Conversely, during obesity the gene expression levels of Cish and Socs2 significantly decrease in the B6 leptin ob/ob mouse at 10 wk, suggesting an enhancement of these properties during a more chronic metabolic stress (Fig. 5B) . Additionally, Socs7-deficient mice display enlarged islets and increased insulin function, consistent with the notion that this family has a role in regulating ß-cell mass in the adult mouse (39) .
Additionally, our comparison of the three paradigms of ß-cell expansion suggests that diverse mechanisms can be used by the islet to expand its mass. The majority of genes investigated are not similarly induced between models, strongly suggesting that not only does the ß-cell have the ability to modulate its mass to cope with metabolic demand, but can also activate diverse signaling mechanisms depending on the physiological condition. In support of this notion, several surprising mechanisms controlling ß-cell mass homeostasis through bone-derived signals (40) , and transmission of pro-proliferative signals from the liver via the peripheral and central nervous system to the ß-cell (41) have been described recently. Conversely, Birc5 and Tnfrsf11b are commonly induced in all three models of ß-cell expansion, suggesting they act as universal mediators of ß-cell expansion. Recently, Birc5 has been shown to exhibit a ß-cell-specific and bifunctional role important in both attenuation of ß-cell proliferation and inhibition of apoptosis in vivo (15) . We show that Birc5 closely mirrors the proliferative profile (mKi67) throughout the ß-cell injury time course (Fig. 5C ), providing additional evidence to suggest that Birc5 is a critical component of the mechanism for maintaining ß-cell homeostasis, not only physiologically, but also in the setting of diabetes.
Tnfrsf11b (Osteoprotegerin) is a secreted and soluble member of the TNF receptor superfamily (42) . Tnfrsf11b has antiapoptotic properties in ß-cells (43) , and overexpression of this osteoblast-derived factor in islets suggests regulation of ß-cell expansion by peripheral tissues, a mechanism supported by transplantation studies in mice (44) . In support of this notion, osteocalcin, a peptide secreted by osteoblasts in the bone, affects energy metabolism, by increasing ß-cell proliferation, insulin secretion, and insulin sensitivity (40) . We hypothesize that Tnfrsf11b is an additional bone-derived hormone that exhibits a pro-proliferative effect on ß-cells during pregnancy. In addition, Keller et al. (16) identified genes in insulin target tissues, specifically muscle, with expression profiles highly correlated to the islet cell cycle regulatory module activated during obesity, including several genes induced in islets during pregnancy, Ngf, Bmp1, and Gdf10 (Gdf3 during pregnancy), suggesting these as further candidates for potentially mediating ß-cell proliferation.
The up-regulation of TGF-ß family members, Bmp1, Alk7, and Gdf3, is consistent with their already known role in establishment of ß-cell mass (45, 46) . In conclusion, we identified a large number of genes correlating with both the initiation and peak of ß-cell proliferation during pregnancy in the mouse. Additionally, we confirmed that many of the genes are expressed in the ß-cell and provide a platform for diabetes researchers to further explore their role in the maintenance of ß-cell mass.
Materials and Methods
ß-Cell mass, ß-cell proliferation, and ß-cell hypertrophy
For histological assessment, pancreata were dissected, fixed in 4% paraformaldehyde for 24 h, and then laid flat for paraffin sectioning. Sections with the greatest surface area were used in all experiments. ß-Cell mass was determined on 4-month-old nonpregnant and pregnant (at d 14.5 of gestation) female mice by point-counting morphometry as previously described (9) . Sections from each animal were stained with guinea pig antiinsulin antibody (1:1000; Linco Research, Inc., St. Charles, MO) diluted in phosphate-buffered saline plus 0.1% Tween and incubated overnight at 4 C. The secondary antiserum was a biotinylated antiguinea pig antibody (1:200; Vector Laboratories, Burlingame, CA). For color development, horseradish peroxidase-conjugated avidin-biotin complex reagent was used with 3,3Ј-diaminobenzidine as a substrate (Vector Laboratories). Images covering the entire section were used from which the percentage of ß-cell area was measured and calculated using MetaMorph Imaging Software (Universal Imaging Corp., West Chester, PA). ß-Cell mass was derived from total pancreas weight multiplied by percentage of ß-cell area (9) . For ß-cell proliferation measurements, mice were injected with 10 l of Zymed BrdU Solution (3 mg/ ml; Zymed Laboratories, Inc., South San Francisco, CA) per gram body weight 24 h before they were euthanized. BrdU staining was assessed using a BrdU-specific sheep monoclonal antibody (1:1000; United States Biochemical Corp., Cleveland, OH) as described (9) . In addition, Ki67 antigen detection using a Ki67-specific rabbit monoclonal (1:2000; Vector Laboratories) antibody was 
FIG. 5.
Gene expression profiles differ between the pregnancy, obesity, and ß-cell injury models of ß-cell regeneration. A, Strain-dependent comparison of mRNA expression of both mKi67 and Birc5 between both 4-and 10-wk-old B6 ob/ob and BTBR ob/ob leptin-deficient mice and lean controls (n ϭ 5-7 per strain; *, P Ͻ 0.05 vs. respective lean control; #, P ϭ 0.055; $, P ϭ 0.08). B, Expression of selected differentially expressed genes identified in the pregnancy paradigm during obesity at 10 wk in the B6 strain (n ϭ 5-7 per strain; *, P Ͻ 0. employed to confirm ß-cell proliferation assessment. For ß-cell size determination, the volume and number of nuclei for each islet were determined using ImageJ Software (Image Processing and Analysis in Java; National Institutes of Health). At least 20 islets per pancreas from at least four mice per experimental group were analyzed for determining ß-cell size and proliferation.
RNA isolation and PCR
Adult islets for all experiments were prepared using the standard collagenase procedure, as previously described (9) . Total RNA was isolated using the RNeasy Mini Kit (QIAGEN, Chatsworth, CA) and eluted in water. Total RNA (200 ng) of each sample was amplified using the MessageAmp aRNA Kit (Ambion, Inc., Austin, TX) (9) . The RNA 6000 Nano Lab Chip Kit with a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) was used to ensure samples of high RNA quality (47) . cDNA was synthesized from approximately 500 ng amplified islet RNA using 1 g of Oligo(dT) primer, SuperScript II Reverse Transcriptase, and accompanying reagents (Invitrogen). PCR mixes were assembled using SYBR Green Quantitative PCR Master Mix (Stratagene, La Jolla, CA). Reactions were performed using the SYBR Green program on the Mx4000 Multiplex Quantitative PCR System (Stratagene). All reactions were performed in duplicate on at least four biological replicates with Rox reference dye normalization. Hprt, Gapdh, and Ubc were tested for suitability as housekeeping genes using the GeNorm analysis package. Median C T values were used for analysis and normalized to the expression of two housekeeping genes, Hprt and Gapdh. Primer sequences are available at http://www.med.upenn.edu/kaestnerlab/.
Microarray expression profiling and data analysis
Nonpregnant controls vs. pregnant at d 14.5
To allow hybridization of samples that were well matched for purity in terms of the amount of exocrine contamination, qPCR was used to determine the relative levels of endocrine (prohormone convertase-2) and exocrine (amylase and chymotrypsinogen B1) gene expression in each sample. As a result, differential gene expression originating from varying islet purity was minimized. Total RNA (50 ng) from each sample was used for labeling and hybridization. Amplified cDNA was prepared using the WT-Ovation Pico Amplification System (NuGEN Technologies, San Carlos, CA). Amplified cDNA (2 g) was directly labeled using the BioPrime Array CGH Genomic Labeling System (Invitrogen) with Cy3-and Cy5-labeled nucleotides (GE Amersham Biosciences, Piscataway, NJ). Of the four biological replicates, two were labeled with Cy3 (test) and the other with Cy5 (control); the other two were labeled with Cy5 (test) and Cy3 (control), eliminating variations introduced by dye bias. Labeled samples were hybridized overnight to the Agilent 4X44 Whole Mouse Genome Array. Arrays were washed and then scanned with the model G2565B Agilent DNA microarray Scanner (Agilent Technologies). Median intensities of each element on the array were captured with Agilent Feature Extraction version 9.53 (Agilent Technologies). Quality control diagnostic plots were prepared for each array, and those failing to exhibit high-quality hybridizations were excluded from further analysis, resulting in the final dataset containing four biological replicates for each condition.
The data were normalized by the print tip loess method using the LIMMA (linear models for microarray data) package in R as described (48) . For statistical analysis, genes were called differentially expressed using the Significance Analysis of Microarrays (SAM) one class response package with a false discovery rate of 20% (49) . Genes marked as absent, i.e. with expression levels near background, were omitted. Differentially expressed genes were confirmed using qPCR as described above. All expression data were deposited into Arrayexpress (Accession no. E-MTAB-120).
Mip-GFP sorting
Freshly isolated islets from Mip-GFP mice (12) were placed in 1.0 ml of prewarmed trypsin at 37 C in an Eppendorf tube for 12 min and mixed every 3 min until no clumps were visible. Dissociation into a single-cell suspension was stopped with the addition of 1 ml of heat-inactivated fetal bovine serum. The cells were then transferred to a 15-ml Falcon tube through a 40-m nylon mesh cell strainer cap (BD Biosciences), washed three times in PBS containing 2% fetal bovine serum, and placed immediately on ice ready for sorting. GFPϩ and GFPϪ cells were sorted by the University of Pennsylvania Flow Cytometry and Cell Sorting Resource Laboratory using the FACSVantage SE (BD Biosciences, Palo Alto, CA). Cells were gated for nonaggregates to achieve a high-purity sort. Both GFPϩ and GFPϪ cells were separated and collected directly into a 1.5-ml Eppendorf tube containing 0.5 ml of Trizol, and the samples were snap frozen in liquid nitrogen and stored at Ϫ80 C. Depending on yield, some samples were pooled to obtain 20,000 cells per sample.
Obesity and reversible ß-cell injury model
Islet RNA isolated from both 10-wk-old B6 ob/ob and BTBR ob/ob leptin-deficient mice was used as an animal model representing obesity. The PANIC-ATTAC mouse was used as an animal model of inducible and reversible ß-cell ablation (17) . Islet RNA was isolated on d 0, d 8, and d 30 after administration of dimerizer AP20187 and cDNA synthesized using the Ovation RNA Amplification System V2 (P/N 3100; NuGEN Technologies). At least four biological replicates per time point were used for qPCR analysis.
Statistical analysis
Statistical analysis between two groups was done using onetailed Student's t test. Values are considered significant when P Ͻ 0.05.
